Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Qualitative Study

Recruiting Observational Study
Cancer Survivors
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Azienda USL Reggio Emilia - IRCCS · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
European Cancer Mission calls attention to the return to work (RTW) of cancer survivors (CSs), as one of the pivotal issues of the cancer continuum that need to be addressed through proper and prompt actions and recommendations. Employers are important stakeholders, as they can provide emotional and practical support, sustain communication during the entire process, and guarantee a gradual work re…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. employers\* of a company 2. being directly involved in managing the RTW process of at least one employee with cancer diagnosis in the last 5 years. * An employer can be the specific person who represents the company where the employee was working at the time of cancer dia…
Contacts

Sara Paltrinieri, PhD, OT

0039 0522 522416

sara.paltrinieri@ausl.re.it

CONTACT

Stefania Costi, PhD, PT

0039 0522 522441

stefania.costi@unimore.it

CONTACT